Oracle Corporation et al v. Druglogic, Inc.

Filing 208

ORDER GRANTING re 207 Stipulation To Shorten Time for the Court to Consider Druglogic's, 204 MOTION for Extension of Time to Complete Discovery Druglogic, Inc.'s Motion to Extend Discovery Period for Limited Purpose. Responses due by 4/10/2013. Replies due by 4/12/2013. Signed by Judge Joseph C. Spero on 4/8/13. (klhS, COURT STAFF) (Filed on 4/8/2013)

1
2
3
4
5
6
7
8
9
10
11
12

Martin L. Fineman (California State Bar No. 104413)
DAVIS WRIGHT TREMAINE LLP
505 Montgomery St., Suite 800
San Francisco, California 94111-6533
Phone: [phone]
Fax: [phone]
E-mail: [e-mail]
Peter Davis (admitted pro hac vice)
Steven E. Tiller (admitted pro hac vice)
Erin O. Millar (admitted pro hac vice)
Gregory Stone (admitted pro hac vice)
WHITEFORD TAYLOR & PRESTON, LLP
7 St. Paul Street
Baltimore, Maryland 21202-1636
Phone: [phone]
Fax: [phone]
Email: [e-mail]
Email: [e-mail]
Email: [e-mail]
Email: [e-mail]
Attorneys for Defendant and Counter-Claimant
DRUGLOGIC, INC.

13
14

IN THE UNITED STATES DISTRICT COURT
FOR THE NORTHERN DISTRICT OF CALIFORNIA

15
ORACLE CORPORATION et al.,

Case No. C 11-00910 JCS

16
17
18

Plaintiffs,
v.
DRUGLOGIC, INC.,
Defendant.

19
20
21
22

THE PARTIES’ STIPULATION TO
SHORTEN TIME FOR THE COURT
TO CONSIDER DRUGLOGIC’S
MOTION TO EXTEND DISCOVERY
FOR LIMITED PURPOSE

DRUGLOGIC, INC.,
Counterclaimant,
v.
ORACLE CORPORATION et al.
Counterclaim Defendants.

23
24
25
26

THE PARTIES’ STIPULATION TO SHORTEN TIME FOR THE COURT TO CONSIDER
DRUGLOGIC’S MOTION TO EXTEND DISCOVERY FOR LIMITED PURPOSE
CASE NO. 11-CV-00910 JCS
DWT 21617657v1 0093218-000001

1

STIPULATION

2

PLEASE TAKE NOTICE that the Parties, Defendant/Counterclaim Plaintiff DrugLogic, Inc.

3

(“DrugLogic”) and Plaintiffs/Counterclaim Defendants Oracle Corporation, Oracle International

4

Corporation, and Oracle America Inc. (collectively, “Oracle”) hereby stipulate to an order shortening the

5

time for the Court to consider DrugLogic’s Motion to Extend Discovery for a Limited Purpose filed on

6

April 5, 2010 (“Motion”). In this regard, the Parties respectfully request that the Court hear the Motion

7

according to the following schedule:

8

•

April 10, 2013 – Oracle’s Opposition to DrugLogic’s motion

9

•

April 12, 2013 – DrugLogic’s Reply in support of its motion

10

•

Hearing to be scheduled at the Court’s discretion, if necessary.

11

Respectfully submitted,

12

/s/ Erin O. Millar
Martin L. Fineman (California State Bar No. 104413)
DAVIS WRIGHT TREMAINE LLP
505 Montgomery St., Suite 800
San Francisco, California 94111-6533
Phone: [phone]
Fax: [phone]
E-mail: [e-mail]

13
14
15
16

Peter Davis (admitted pro hac vice)
Steven E. Tiller (admitted pro hac vice)
Erin O. Millar (admitted pro hac vice)
Gregory M. Stone (admitted pro hac vice)
WHITEFORD TAYLOR & PRESTON, LLP
7 St. Paul Street
Baltimore, Maryland 21202-1636
Phone: [phone]
Fax: [phone]
Email: [e-mail]
Email: [e-mail]
Email: [e-mail]
Email: [e-mail]

17
18
19
20
21
22
23

Attorneys for Defendant and Counter-Claimant

24
25
26

THE PARTIES’ STIPULATION TO SHORTEN TIME FOR THE COURT TO CONSIDER
DRUGLOGIC’S MOTION TO EXTEND DISCOVERY FOR LIMITED PURPOSE
CASE NO. 11-CV-00910 JCS
DWT 21617657v1 0093218-000001

-2-

1

DRUGLOGIC, INC.

2

/s/ Christina Von de Ahe
Karen Johnson-McKewan
[e-mail]
Christina Von Der Ahe
[e-mail]
ORRICK, HERRINGTON & SUTCLIFFE, LLP
The Orrick Building
405 Howard Street
San Francisco, CA 94105-2669

3
4
5
6
7

I. Neel Chatterjee
[e-mail]
Michael C. Spillner
[e-mail]
ORRICK, HERRINGTON & SUTCLIFFE, LLP
1000 Marsh Road
Menlo Park, CA 94025

8
9
10
11

Deborah K. Miller (California State Bar. No. 95527)
[e-mail]
Peggy E. Bruggman (California State Bar No. 184176)
[e-mail]
Lesley E. Kothe (California State Bar No. 209512)
[e-mail]
ORACLE CORPORATION
500 Oracle Parkway
Redwood City, California 94065

12
13
14
15
16
S

RT

ER

21

R NIA

seph C.

Spero

A

H

20

Judge Jo

FO

NO

19

ERED

O ORD
IT IS S

LI

Dated: April 8, 2013

UNIT
ED

18

RT
U
O

17

ISTRIC
ES D
TC
AT
T

N

F
D IS T IC T O
R

C

22
23
24
25
26

THE PARTIES’ STIPULATION TO SHORTEN TIME FOR THE COURT TO CONSIDER
DRUGLOGIC’S MOTION TO EXTEND DISCOVERY FOR LIMITED PURPOSE
CASE NO. 11-CV-00910 JCS
DWT 21617657v1 0093218-000001

-3-

1
2
3
4

CERTIFICATE OF SERVICE
The undersigned hereby certifies that on April 5, 2013 the foregoing
STIPULATION TO SHORTEN TIME FOR THE COURT TO CONSIDER DRUGLOGIC’S
MOTION TO EXTEND DISCOVERY FOR LIMITED PURPOSE
was served on the following persons via first-class mail, postage prepaid and email:

5

Karen Johnson-McKewan
[e-mail]
Christina Von Der Ahe
[e-mail]
ORRICK, HERRINGTON & SUTCLIFFE, LLP
The Orrick Building
405 Howard Street
San Francisco, CA 94105-2669

6
7
8
9

I. Neel Chatterjee
[e-mail]
Michael C. Spillner
[e-mail]
ORRICK, HERRINGTON & SUTCLIFFE, LLP
1000 Marsh Road
Menlo Park, CA 94025

10
11
12
13

Deborah K. Miller (California State Bar. No. 95527)
[e-mail]
Peggy E. Bruggman (California State Bar No. 184176)
[e-mail]
Lesley E. Kothe (California State Bar No. 209512)
[e-mail]
ORACLE CORPORATION
500 Oracle Parkway
Redwood City, California 94065

14
15
16
17
18

Attorneys for Oracle Corporation, Oracle
International Corporation, and Phase Forward,

19
20

I certify that all parties in this case are represented by counsel who are CM/ECF participants.

21

/s/ Erin O. Millar
Attorneys for Defendant and Counterclaimant, DRUGLOGIC,
INC.

22
23
24
25
26

THE PARTIES’ STIPULATION TO SHORTEN TIME FOR THE COURT TO CONSIDER
DRUGLOGIC’S MOTION TO EXTEND DISCOVERY FOR LIMITED PURPOSE
CASE NO. 11-CV-00910 JCS
DWT 21617657v1 0093218-000001

-4-